Form 4: Intuitive Surgical EVP Jamie Samath Reports Stock Transactions

EVP & CFO of Intuitive Surgical, Jamie Samath, reports multiple transactions involving common stock and derivative securities, including acquisitions, disposals, and exercises of stock options and restricted stock units.

Summary

• Jamie Samath, EVP & CFO of Intuitive Surgical, filed a Form 4 detailing changes in beneficial ownership.
• The transactions include the acquisition of 3,758 shares of common stock related to performance stock units (PSUs) on February 27, 2025.
• On February 28, 2025, Samath exercised stock options to acquire 94 shares at $290.33 and 94 shares at $208.9.
• Also on February 28, 2025, 752 Restricted Stock Units (RSUs) were converted to common stock.
• A total of 2,426 shares were disposed of to cover tax obligations related to the settlement of PSUs and RSUs.
• The reported transactions were executed in accordance with a pre-arranged trading plan under SEC Rule 10b5-1, expiring on May 6, 2025.
• Following these transactions, Samath directly owns 7,162 shares of common stock and holds derivative securities including 1,128 non-qualified stock options at exercise prices of $208.9 and $290.33, and 752 RSUs.

Sentiment

Score: 5

Explanation: The document is a routine disclosure of stock transactions by a company executive. It doesn't inherently convey positive or negative sentiment, but rather provides factual information.

Future Outlook

The executive's future transactions may continue under the existing 10b5-1 trading plan until its expiration on May 6, 2025.

Industry Context

Executive stock transactions are a common occurrence in publicly traded companies like Intuitive Surgical. Monitoring these transactions can provide insights into management's perspective on the company's performance and future prospects.

Comparison to Industry Standards

• Executive compensation packages often include stock options and restricted stock units to align management's interests with those of shareholders.
• The vesting schedules and exercise prices of these instruments are generally in line with industry standards for technology and medical device companies.
• Trading plans under SEC Rule 10b5-1 are a common mechanism for executives to manage their stock transactions while avoiding accusations of insider trading.

Stakeholder Impact

• The transactions may have a minor impact on shareholders due to the change in the number of shares outstanding.
• The transactions do not directly impact employees, customers, suppliers, or creditors.

Key Dates